Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CKD-351 for efficacy and safety in primary open-angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• CKD-351

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Primary Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: UNKNOWN